Endocrinology

Host: Mimi Secor, DNP, FNP-BC, FAANP

Guest: Felicia Cosman, MD

How can factors like nutrition, alcohol intake, and physical activity impact our patients’ bone health? Find out what the top research over the past decade on osteoporosis is saying on these topics and more with Dr. Felicia Cosman, Coeditor in Chief of the Osteoporosis International journal and Professor of Clinical Medicine at Columbia University Medical Center in New York.

Host: Mimi Secor, DNP, FNP-BC, FAANP

Guest: Felicia Cosman, MD

Here to bring to light highly sited articles over the past decade from the leading journal in osteoporosis that address the way we approach patients living with osteoporosis and the different treatment options we can use to help them is Dr. Felicia Cosman, Coeditor in Chief of the Osteoporosis International journal and Professor of Clinical Medicine at Columbia University Medical Center in New York.

Host: Mario R. Nacinovich, Jr., MSc

Guest: Paul Orchard, MD

Although it only affects about one in 18,000 people, the impacts of adrenoleukodystrophy cannot be underestimated. That’s why Dr. Paul Orchard joins Mario Nacinovich to talk about this rare—and fatal—genetic disease, why it’s often underdiagnosed and confused with other conditions, and how we can treat it once we’ve reached an accurate diagnosis.

Host: Barnett Mennen, MD

Guest: Sarah Hallberg, MD

Carbohydrates are our main source of energy and provide important nutrients for good health. However, they are also the main culprit behind elevated blood sugar and are problematic for diabetic patients trying to control their blood sugar levels.

Host Dr. Barry Mennen sits down with Dr. Sarah Hallberg to talk about carbohydrate restriction as a key to successful weight loss programs. She prescribes that adherence to a low-carb, high-fat diet is vital to patients for controlling their diabetes, with the possibility of being able to come off medications over time.

Dr. Sarah Hallberg is the Medical Director at Virta Health and Founder of the Indiana University-Arnett Health Medical Weight Loss Program in Lafayette, Indiana.

Based on new data from two large clinical trials, the FDA concluded that the type 2 diabetes medicine canagliflozin (brand names Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. The FDA is requiring new warnings, including their most prominent Boxed Warning, be added to the canagliflozin drug labels to describe this risk.

Amputations of the toe and middle of the foot were the most common; however, amputations involving the leg, below and above the knee, also occurred. Some patients had more than one amputation, some involving both limbs.

Report side effects involving canagliflozin and other medicines to the FDA MedWatch program at fda.gov/medwatch.

A link to the full communication detailing specific information for health care professionals and the complete Data Summary can be found at fda.gov/DrugSafetyCommunications. If you have drug questions, contact the FDA at [email protected].

Released 5/16/2017

Host: Brian P. McDonough, MD, FAAFP

Polycystic Ovary Syndrom (PCOS) afflicts 10 to 15% of women worldwide, yet physicians often don't recognize the symptoms associated with this disease.

Host Dr. Brian McDonough chats with Dr. Fiona McCulloch, a Toronto-based naturopath and author of the book 8 Steps to Reverse Your PCOS, about different approaches to managing PCOS and how dietary changes can make huge impacts for women dealing with PCOS.

Host: Kathy King, RDN

Joining Kathy King to talk about vitamin D at the molecular, physiological, and clinical levels is Susan Allen, certified clinical nutritionist and owner of Next Level Functional Nutrition based in Tampa, FL.

Host: Brian P. McDonough, MD, FAAFP

Diabulimia, defined as the manipulation of insulin treatments by Type 1 diabetic patients in order to lose weight, is a rising problem among teens and young adults in the U.S, particularly young women. Joining Dr. Brian McDonough to discuss this dual diagnosis phenomenon of diabetes and eating disorders, ways in which they exacerbate other disease processes, the long term consequences, and management priorities for phycisians is author and registered dietitian Susan Weiner. Susan is a recipient of the AADE Diabetes Educator of the Year award and has devoted much of her writing and clinical expertise to addressing diabulimia in at-risk patients.

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG

Many menopausal and perimenopausal women are faced with the decision of whether synthetic or bioidentical hormone therapy is the best option for them. There are many pros and cons for each, but questions surface from patients and clinicians alike on comparative safety and efficacy profiles.

Host Dr. Renee Allen welcomes Dr. Jocelyn Slaughter-Moore, a board-certified practicing OB/GYN at Heras Healthcare for Women. They talk about the differences between bioidentical and synthetic hormones, and whether bioidentical hormone therapy is a safe option for women.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA

Guest: Joyce Ross

Host Dr. Alan Brown welcomes Joyce Ross, nurse practitioner and President of the National Lipid Association. Joyce is a consultative education specialist in Cardiovascular Risk Intervention with the University of Pennsylvania Health System. She is the first Nurse Practitioner elected as President of the NLA.

Ms. Ross introduces her goals for the upcoming year, including novel efforts on behalf of the NLA to help combat America's obesity epidemic.